{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:45:27Z","timestamp":1791985527962,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05142-4","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:45:06Z","timestamp":1784526306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of machine perfusion in preventing recurrence after liver transplant for hepatocellular carcinoma: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9797-851X","authenticated-orcid":false,"given":"Ibrahim U.","family":"Garzali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ez El Din","family":"Abou zeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Aloun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina I.","family":"Elyakub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman A.","family":"Sheshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"5142_CR1","doi-asserted-by":"crossref","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673622012004.","DOI":"10.1016\/S0140-6736(22)01200-4"},{"key":"5142_CR2","doi-asserted-by":"publisher","unstructured":"Luo W-L, Wang Q-B, Li Y-K, Liang Y-B, Li J, Chen X-M et al. Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective Study. J Hepatocell Carcinoma. 2025;12(null):2681\u201392. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/https:\/\/doi.org\/10.2147\/JHC.S556306.","DOI":"10.2147\/JHC.S556306"},{"key":"5142_CR3","doi-asserted-by":"publisher","unstructured":"Wang Q-B, Luo W-L, Li Y-K, Li J, Yang Z-S, Zhao K et al. Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study. J Hepatocell Carcinoma. 2025;12(null):2055\u201367. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/https:\/\/doi.org\/10.2147\/JHC.S544589.","DOI":"10.2147\/JHC.S544589"},{"key":"5142_CR4","doi-asserted-by":"crossref","unstructured":"Terrault NA, Francoz C, Berenguer M, Charlton M, Heimbach J, Liver Transplantation. 2023: Status Report, Current and Future Challenges. Clin Gastroenterol Hepatol 2023;21(8):2150\u201366. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356523002781.","DOI":"10.1016\/j.cgh.2023.04.005"},{"key":"5142_CR5","doi-asserted-by":"crossref","unstructured":"Jochum C, Canbay A. Liver Transplantation as Cure of Hepatocellular Carcinoma: It is not a Matter of Time, it is a Matter of Tumor Biology. Ann Hepatol. 2017;16(3):326\u20137. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119304028.","DOI":"10.5604\/16652681.1235472"},{"key":"5142_CR6","doi-asserted-by":"publisher","unstructured":"Ince V, Akbulut S, Otan E, Ersan V, Karakas S, Sahin TT et al. Liver Transplantation for Hepatocellular Carcinoma: Malatya Experience and Proposals for Expanded Criteria. J Gastrointest Cancer. 2020;51(3):998\u20131005. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12029-020-00424-w.","DOI":"10.1007\/s12029-020-00424-w"},{"key":"5142_CR7","doi-asserted-by":"publisher","unstructured":"Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis. N Engl J Med. 1996;334(11):693\u2013700. Available from: http:\/\/www.nejm.org\/doi\/abs\/https:\/\/doi.org\/10.1056\/NEJM199603143341104.","DOI":"10.1056\/NEJM199603143341104"},{"key":"5142_CR8","doi-asserted-by":"crossref","unstructured":"Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10(1):35\u201343. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204508702845.","DOI":"10.1016\/S1470-2045(08)70284-5"},{"key":"5142_CR9","doi-asserted-by":"crossref","unstructured":"Filgueira NA. Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation. World J Hepatol. 2019;11(3):261\u201372. Available from: https:\/\/www.wjgnet.com\/1948-5182\/full\/v11\/i3\/261.htm.","DOI":"10.4254\/wjh.v11.i3.261"},{"key":"5142_CR10","doi-asserted-by":"crossref","unstructured":"Bzeizi KI, Abdullah M, Vidyasagar K, Alqahthani SA, Broering D. Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence. Cancers (Basel). 2022;14(20):5114. Available from: https:\/\/www.mdpi.com\/2072-6694\/14\/20\/5114.","DOI":"10.3390\/cancers14205114"},{"key":"5142_CR11","doi-asserted-by":"crossref","unstructured":"ALoun A, Garzali IU, Abouzeid EE. Does mTORi base immunosuppression offer survival advantage after liver transplantation for hepatocellular carcinoma? Systematic review and meta-analysis of randomized controlled trials. Hepatol Forum. 2023;4(2):82\u20138. Available from: https:\/\/hepatologyforum.org\/storage\/upload\/pdfs\/1684403797-en.pdf.","DOI":"10.14744\/hf.2022.2022.0049"},{"key":"5142_CR12","doi-asserted-by":"crossref","unstructured":"Stra\u015b WA, Wasiak D, \u0141\u0105giewska B, Tronina O, Hre\u0144czuk M, Gotlib J et al. Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models. Ann Transplant 2022;27. Available from: https:\/\/www.annalsoftransplantation.com\/abstract\/index\/idArt\/934924.","DOI":"10.12659\/AOT.934924"},{"key":"5142_CR13","doi-asserted-by":"crossref","unstructured":"Sposito C, Citterio D, Virdis M, Battiston C, Busset MDD, Flores M et al. Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma. World J Gastroenterol. 2022;28(34):4929\u201342. Available from: https:\/\/www.wjgnet.com\/1007-9327\/full\/v28\/i34\/4929.htm.","DOI":"10.3748\/wjg.v28.i34.4929"},{"key":"5142_CR14","doi-asserted-by":"crossref","unstructured":"Maspero M, Yilmaz S, Cazzaniga B, Raj R, Ali K, Mazzaferro V et al. The role of ischaemia-reperfusion injury and liver regeneration in hepatic tumour recurrence. JHEP Reports. 2023;5(11):100846. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923001775.","DOI":"10.1016\/j.jhepr.2023.100846"},{"key":"5142_CR15","doi-asserted-by":"publisher","unstructured":"Yang F, Zhang Y, Ren H, Wang J, Shang L, Liu Y et al. Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis. J Exp Clin Cancer Res. 2019;38(1):489. Available from: https:\/\/jeccr.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13046-019-1480-9.","DOI":"10.1186\/s13046-019-1480-9"},{"key":"5142_CR16","doi-asserted-by":"crossref","unstructured":"Gr\u0105t M, Krawczyk M, Wronka KM, Stypu\u0142kowski J, Lewandowski Z, Wasilewicz M et al. Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation. Sci Rep. 2018;8(1):8935. Available from: https:\/\/www.nature.com\/articles\/s41598-018-27319-y.","DOI":"10.1038\/s41598-018-27319-y"},{"key":"5142_CR17","doi-asserted-by":"crossref","unstructured":"Parente A, Flores Carvalho M, Eden J, Dutkowski P, Schlegel A. Mitochondria and Cancer Recurrence after Liver Transplantation\u2014What Is the Benefit of Machine Perfusion? Int J Mol Sci. 2022;23(17):9747. Available from: https:\/\/www.mdpi.com\/1422-0067\/23\/17\/9747.","DOI":"10.3390\/ijms23179747"},{"key":"5142_CR18","doi-asserted-by":"publisher","unstructured":"Knijff LWD, van Kooten C, Ploeg RJ. The Effect of Hypothermic Machine Perfusion to Ameliorate Ischemia-Reperfusion Injury in Donor Organs. Front Immunol. 2022;13. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2022.848352\/full.","DOI":"10.3389\/fimmu.2022.848352\/full"},{"key":"5142_CR19","doi-asserted-by":"crossref","unstructured":"Schlegel A, Muller X, Mueller M, Stepanova A, Kron P, de Rougemont O et al. Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation. EBioMedicine. 2020;60:103014. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642030390X.","DOI":"10.1016\/j.ebiom.2020.103014"},{"key":"5142_CR20","doi-asserted-by":"crossref","unstructured":"Luo J, Hu Y, Qiao Y, Li H, Huang J, Xu K et al. Hypothermic Oxygenated Machine Perfusion Promotes Mitophagy Flux against Hypoxia-Ischemic Injury in Rat DCD Liver. Int J Mol Sci. 2023;24(6):5403. Available from: https:\/\/www.mdpi.com\/1422-0067\/24\/6\/5403.","DOI":"10.3390\/ijms24065403"},{"key":"5142_CR21","doi-asserted-by":"crossref","unstructured":"Jassem W, Xystrakis E, Ghnewa YG, Yuksel M, Pop O, Martinez-Llordella M et al. Normothermic Machine Perfusion (NMP) Inhibits Proinflammatory Responses in the Liver and Promotes Regeneration. Hepatology. 2019;70(2):682\u201395. Available from: https:\/\/journals.lww.com\/01515467-201908000-00022.","DOI":"10.1002\/hep.30475"},{"key":"5142_CR22","doi-asserted-by":"publisher","unstructured":"Tang Y, Wang T, Ju W, Li F, Zhang Q, Chen Z et al. Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Front Oncol. 2021;11. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fonc.2021.773535\/full.","DOI":"10.3389\/fonc.2021.773535\/full"},{"key":"5142_CR23","doi-asserted-by":"crossref","unstructured":"Schlegel A, Muller X, Kalisvaart M, Muellhaupt B, Perera MTPR, Isaac JR et al. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation. J Hepatol. 2019;70(1):50\u20137. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827818324577.","DOI":"10.1016\/j.jhep.2018.10.005"},{"key":"5142_CR24","doi-asserted-by":"publisher","unstructured":"Mueller M, Kalisvaart M, O\u2018Rourke J, Shetty S, Parente A, Muller X et al. Hypothermic Oxygenated Liver Perfusion (HOPE) Prevents Tumor Recurrence in Liver Transplantation From Donation After Circulatory Death. Ann Surg. 2020;272(5):759\u201365. Available from: https:\/\/journals.lww.com\/https:\/\/doi.org\/10.1097\/SLA.0000000000004258.","DOI":"10.1097\/SLA.0000000000004258"},{"key":"5142_CR25","doi-asserted-by":"crossref","unstructured":"Rigo F, De Stefano N, Patrono D, De Donato V, Campi L, Turturica D et al. Impact of Hypothermic Oxygenated Machine Perfusion on Hepatocellular Carcinoma Recurrence after Liver Transplantation. J Pers Med. 2023;13(5):703. Available from: https:\/\/www.mdpi.com\/2075-4426\/13\/5\/703.","DOI":"10.3390\/jpm13050703"},{"issue":"633","key":"5142_CR26","doi-asserted-by":"publisher","first-page":"217970","DOI":"10.1016\/j.canlet.2025.217970","volume":"7","author":"W Shu","year":"2025","unstructured":"Shu W, Chen H, Wang R, Song J, Tang R, Wu G. Machine perfusion prevents early tumor recurrence in liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study. Cancer Lett. 2025;7(633):217970.","journal-title":"Cancer Lett"},{"key":"5142_CR27","doi-asserted-by":"publisher","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14, 135(2014). https:\/\/doi.org\/10.1186\/1471-2288-14-135.","DOI":"10.1186\/1471-2288-14-135"},{"key":"5142_CR28","doi-asserted-by":"publisher","first-page":"e1883","DOI":"10.1097\/TXD.0000000000001883","volume":"12","author":"DT Koch","year":"2026","unstructured":"Koch DT, Pollety L, Schirren M, Jacobi S, B\u00f6rner N, Lange CM, et al. HCC Recurrence Rates After DBD Liver Transplantation in Times of Machine Perfusion. Transpl Direct. 2026;12:e1883.","journal-title":"Transpl Direct"},{"key":"5142_CR29","doi-asserted-by":"publisher","first-page":"e1777","DOI":"10.1097\/TXD.0000000000001777","volume":"11","author":"LE Matevish","year":"2025","unstructured":"Matevish LE, Guo J, Shubin AD, Macconmara M, Hwang CS, Raschzok N, et al. Transplantation of Patients with Hepatocellular Carcinoma Through Increased Utilization of Machine Perfusion Technology. Transpl Direct. 2025;11:e1777.","journal-title":"Transpl Direct"},{"key":"5142_CR30","doi-asserted-by":"publisher","unstructured":"Schlegel A, Mueller M, Muller X, Eden J, Panconesi R, Felten S, Von et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before trans. J Hepatol. 2023;78(4):783\u201393. Available from: https:\/\/doi.org\/10.1016\/j.jhep.2022.12.030.","DOI":"10.1016\/j.jhep.2022.12.030"},{"key":"5142_CR31","doi-asserted-by":"crossref","unstructured":"Eden J, M\u00fcller PC, Kuemmerli C, Bongini M, Albanesi F, Sposito C et al. HCC recurrence in liver transplants treated with hypothermic oxygenated machine perfusion: an international matched cohort study. JHEP Rep 2026;101732.","DOI":"10.1016\/j.jhepr.2026.101732"},{"key":"5142_CR32","doi-asserted-by":"publisher","unstructured":"Dajti G, Germinario G, Prosperi E, Siniscalchi A, Vasuri F, Valente S et al. The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation. Artif Organs.2024;48(6):619\u2013625 https:\/\/doi.org\/10.1111\/aor.14715.","DOI":"10.1111\/aor.14715"},{"key":"5142_CR33","doi-asserted-by":"crossref","unstructured":"Verna EC, Patel YA, Aggarwal A, Desai AP, Frenette C, Pillai AA et al. Liver transplantation for hepatocellular carcinoma: Management after the transplant. Am J Transplant. 2020;20(2):333\u201347. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522221868.","DOI":"10.1111\/ajt.15697"},{"key":"5142_CR34","doi-asserted-by":"crossref","unstructured":"Yang JD, Larson JJ, Watt KD, Allen AM, Wiesner RH, Gores GJ et al. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States. Clin Gastroenterol Hepatol. 2017;15(5):767\u2013775.e3. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356516312265.","DOI":"10.1016\/j.cgh.2016.11.034"},{"key":"5142_CR35","doi-asserted-by":"crossref","unstructured":"Garzali IU, Hargura AS, Ince V, Varol I, Carr BI, Yilmaz S. Liver Transplantation for Hepatocellular Carcinoma in Patients with Inherited Metabolic Liver Diseases: A Single-Center Analysis. Turkish J Gastroenterol. 2023;34:1235\u20139. Available from: https:\/\/turkjgastroenterol.org\/en\/liver-transplantation-for-hepatocellular-carcinoma-in-patients-with-inherited-metabolic-liver-diseases-a-single-center-analysis-137122.","DOI":"10.5152\/tjg.2023.22679"},{"key":"5142_CR36","doi-asserted-by":"publisher","unstructured":"Li PJ, Shah S, Mehta N. Recent Advances in Liver Transplantation for Hepatocellular Carcinoma. Curr Treat Options Oncol. 2024;25(9):1153\u201362. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s11864-024-01247-8.","DOI":"10.1007\/s11864-024-01247-8"},{"key":"5142_CR37","doi-asserted-by":"crossref","unstructured":"Kotsifa E, Vergadis C, Vailas M, Machairas N, Kykalos S, Damaskos C et al. Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How? J Pers Med. 2022;12(3):436. Available from: https:\/\/www.mdpi.com\/2075-4426\/12\/3\/436.","DOI":"10.3390\/jpm12030436"},{"key":"5142_CR38","doi-asserted-by":"crossref","unstructured":"Safavi AH, Dawson LA, Mesci A. Do We Have a Winner? Advocating for SBRT in HCC Management. Clin Transl Radiat Oncol. 2024;45:100740. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082400017X.","DOI":"10.1016\/j.ctro.2024.100740"},{"key":"5142_CR39","doi-asserted-by":"crossref","unstructured":"Hogen R, Barry T, Subramanian V. Expanding Indications for Liver Transplantation in the Treatment of Hepatocellular Carcinoma. Curr Oncol. 2024;31(8):4753\u201361. Available from: https:\/\/www.mdpi.com\/1718-7729\/31\/8\/355.","DOI":"10.3390\/curroncol31080355"},{"key":"5142_CR40","doi-asserted-by":"crossref","unstructured":"Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K et al. Liver Resection as a Bridge to Transplantation for Hepatocellular Carcinoma on Cirrhosis. Ann Surg. 2003;238(4):508\u201319. Available from: https:\/\/journals.lww.com\/00000658-200310000-00006.","DOI":"10.1097\/01.sla.0000090449.87109.44"},{"key":"5142_CR41","doi-asserted-by":"publisher","unstructured":"Amaddeo G, Allaire M, Franz\u00e8 MS, Dupr\u00e9 C, Caruso S, Antonini T et al. Feasibility and Effectiveness of Liver Transplantation following Immunotherapy in Patients with Hepatocellular Carcinoma. Liver Cancer 2025;Available from: https:\/\/doi.org\/10.1159\/000548608.","DOI":"10.1159\/000548608"},{"key":"5142_CR42","doi-asserted-by":"crossref","unstructured":"Soares ROS, Losada DM, Jordani MC, \u00c9vora P, Castro-e-Silva O. Ischemia\/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies. Int J Mol Sci. 2019;20(20):5034. Available from: https:\/\/www.mdpi.com\/1422-0067\/20\/20\/5034.","DOI":"10.3390\/ijms20205034"},{"key":"5142_CR43","doi-asserted-by":"crossref","unstructured":"Cannistr\u00e0 M, Ruggiero M, Zullo A, Gallelli G, Serafini S, Maria M et al. Hepatic ischemia reperfusion injury: A systematic review of literature and the role of current drugs and biomarkers. Int J Surg. 2016;33:S57\u201370. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919116301364.","DOI":"10.1016\/j.ijsu.2016.05.050"},{"key":"5142_CR44","doi-asserted-by":"publisher","unstructured":"Dar WA, Sullivan E, Bynon JS, Eltzschig H, Ju C. Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms. Liver Int. 2019;39(5):788\u2013801. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/liv.14091.","DOI":"10.1111\/liv.14091"},{"key":"5142_CR45","doi-asserted-by":"crossref","unstructured":"Tchilikidi KY. Liver graft preservation methods during cold ischemia phase and normothermic machine perfusion. World J Gastrointest Surg. 2019;11(3):126\u201342. Available from: https:\/\/www.wjgnet.com\/1948-9366\/full\/v11\/i3\/126.htm.","DOI":"10.4240\/wjgs.v11.i3.126"},{"key":"5142_CR46","doi-asserted-by":"crossref","unstructured":"Widmer J, Eden J, Carvalho MF, Dutkowski P, Schlegel A. Machine Perfusion for Extended Criteria Donor Livers: What Challenges Remain? J Clin Med. 2022;11(17):5218. Available from: https:\/\/www.mdpi.com\/2077-0383\/11\/17\/5218.","DOI":"10.3390\/jcm11175218"},{"key":"5142_CR47","doi-asserted-by":"crossref","unstructured":"Cursio R, Gugenheim J. Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation. J Transplant. 2012;2012:1\u201317. Available from: http:\/\/www.hindawi.com\/journals\/jtrans\/2012\/164329\/.","DOI":"10.1155\/2012\/164329"},{"key":"5142_CR48","doi-asserted-by":"crossref","unstructured":"Agostini C, Buccianti S, Risaliti M, Fortuna L, Tirloni L, Tucci R et al. Complications in Post-Liver Transplant Patients. J Clin Med. 2023;12(19):6173. Available from: https:\/\/www.mdpi.com\/2077-0383\/12\/19\/6173.","DOI":"10.3390\/jcm12196173"},{"key":"5142_CR49","doi-asserted-by":"crossref","unstructured":"Garzali IU, Aloun A, Abuzeid EED. Early outcome of machine perfusion vs static cold storage of liver graft: A systemic review and meta-analysis of randomized controlled trials. Hepatol Forum 2024;Available from: https:\/\/hepatologyforum.org\/storage\/upload\/pdfs\/1708584480-en.pdf.","DOI":"10.14744\/hf.2023.2023.0069"},{"key":"5142_CR50","doi-asserted-by":"publisher","unstructured":"Zheng W-J, Xu Y, Tan H, Chen S-G, Wang P-X, Sun H-X et al. 18F-FDG PET\/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation. Liver Cancer. 2025;14(5):518\u201338. Available from: https:\/\/doi.org\/10.1159\/000544966.","DOI":"10.1159\/000544966"},{"key":"5142_CR51","doi-asserted-by":"publisher","unstructured":"Castelli FA, Rosati G, Moguet C, Fuentes C, Marrugo-Ram\u00edrez J, Lefebvre T et al. Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests. Anal Bioanal Chem. 2022;414(2):759\u201389. Available from: https:\/\/doi.org\/10.1007\/s00216-021-03586-z.","DOI":"10.1007\/s00216-021-03586-z"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05142-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05142-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05142-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:52:05Z","timestamp":1791982325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05142-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5142"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05142-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"643"}}